Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Everyone wins. Patients win by gaining access to more effective treatments, and our partners win by increasing profits and improving clinical outcomes.
CT-100: Click Neurobehavioral Intervention (CNI) Platform
Major Depressive Disorder
What is a digital therapeutic?
Digital therapeutics utilize software to treat a disease, and may also include ancillary components such as connected hardware device(s), adjunctive pharmacotherapy, or live clinical support, but the software component could still drive meaningful outcomes as an independent contributor to treatment.
DIGITAL THERAPEUTIC CALCULATOR